{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T12:08:01.157869+00:00","company":{"ticker":"PRAX","cik":1689548,"company_name":"Praxis Precision Medicines, Inc."},"pagination":{"limit":100,"returned":2,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"1fc20779c9400ae1cab3c77a86a38a1527bfdc88","cik":1689548,"ticker":"PRAX","company_name":"Praxis Precision Medicines, Inc.","filed_at":"2024-05-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$39.6 million","period_text":"the first quarter 2024","report_date":"2024-05-13","result_type":"reported_results","revenue_text":null},"claim":"Praxis Precision Medicines, Inc. reported the first quarter 2024 results: net income $39.6 million.","evidence_excerpt":"Praxis Precision Medicines, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001689548-24-000058","anchor_url":"https://secwatch.observer/filing/0001689548-24-000058#claim-1fc20779c9400ae1cab3c77a86a38a1527bfdc88","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954824000058/0001689548-24-000058-index.htm"},{"fact_type":"earnings_release","fact_key":"5a45a0b8e501ed15eea0f67f256ea5e6299a3632","cik":1689548,"ticker":"PRAX","company_name":"Praxis Precision Medicines, Inc.","filed_at":"2024-03-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fourth quarter and full-year 2023","report_date":"2024-03-05","result_type":"reported_results","revenue_text":null},"claim":"Praxis Precision Medicines, Inc. reported financial results for fourth quarter and full-year 2023.","evidence_excerpt":"On March 5, 2024, Praxis Precision Medicines, Inc. (the “Company”) announced its financial results for the quarter and full year ended December 31, 2023.","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001689548-24-000035","anchor_url":"https://secwatch.observer/filing/0001689548-24-000035#claim-5a45a0b8e501ed15eea0f67f256ea5e6299a3632","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954824000035/0001689548-24-000035-index.htm"}]}